2013-02-07 16:02:58 - New Pharmaceuticals market report from GlobalData: "Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Strategic SWOT Analysis Review"

Amsterdam Molecular Therapeutics (AMT) Holding N.V. (AMT), formerly Amsterdam Molecular Therapeutics (AMT) Holding B.V., is a bio-pharmaceutical company with focus on developing gene-based therapies for orphan diseases. The company develops gene therapies to treat metabolic disorders, liver diseases, blood diseases, and disorders of the central and peripheral nervous systems. Its product pipeline comprises Glybera, hemophilia B gene therapy, AMT-080, AMT-021, AMT-090 and the Institut Pasteur program. It also developed an adeno-associated viral (AAV) production platform by using AAV vectors as the delivery vehicle of choice for therapeutic genes.


Full Report Details at
- www.fastmr.com/prod/536252_amsterdam_molecular_therapeutics_amt_ ..


Amsterdam Molecular Therapeutics (AMT) Holding N.V. Key Recent Developments

Apr 26, 2012: Amsterdam Molecular Therapeutics Reports 2011 Resultsn

GlobalData's Amsterdam

Molecular Therapeutics (AMT) Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - GlobalData's summarization of the company's business strategy.
* SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

* Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
* Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
* Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
* Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Key Facts
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Key Employees
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Key Employee Biographies
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Major Products and Services
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - History
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Company Statement
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Business Description
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - SWOT Analysis
SWOT Analysis - Overview
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Strengths
Strength - Strong In-house Research Expertise
Strength - Modular Technology Platform
Strength - Intellectual Property
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Weaknesses
Weakness - Delay in Approval of Glybera
Weakness - Weak Financial Position
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Opportunities
Opportunity - Orphan Drug Designation
Opportunity - Strong Pipeline Products
Opportunity - Market Potential: Parkinson's disease
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Threats
Threat - Increasing Competitive Pressure
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Key Competitors
Section 3 - Company's Lifesciences Financial Deals and Alliances
Amsterdam Molecular Therapeutics (AMT) Holding N.V., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Amsterdam Molecular Therapeutics (AMT) Holding N.V., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Amsterdam Molecular Therapeutics (AMT) Holding N.V., Recent Deals Summary
Section 4 - Company's Recent Developments
Amsterdam Molecular Therapeutics (AMT) Holding N.V., Recent Developments
Apr 26, 2012: Amsterdam Molecular Therapeutics Reports 2011 Results
Section 5 - Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=536252&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.